And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Given the circumstances, our agenda is rather modest. We plan to gaze at the telly now and then, promenade with the official mascot, putter around the castle, and catch up on our reading. And what about you? This remains a fine time to appreciate the great outdoors. Perhaps a drive-in movie is a possibility. Or you may want to reach out to someone feeling a bit isolated these days. Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you soon…

President Trump signed an executive order Thursday directing the federal government to buy certain drugs solely from American factories, STAT reports. The “Buy American” order could represent a seismic shakeup of the pharmaceutical industry. No one knows exactly how much of the American supply chain is produced abroad, but some experts insist up to 90% of critical generic drugs are made at least partially abroad. It remains unclear, however, how broadly the order will be implemented — the executive order does not specify what drugs it covers.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy